Long-term pirfenidone treatment in the Russian patients with idiopathic pulmonary fibrosis

Download in PDF

Aim

To assess the safety and efficacy of the long-term antifibrotic therapy with pirfenidone in patients with idiopathic pulmonary fibrosis in real-life clinical practice.

Material and methods

Disease symptoms, FVC, DLCO) and 6-minute walk test were monitored in 5 patients with IPF who received long-term treatment with pirfenidone.

Results

Long-term follow-up (13-51 months) showed treatment safety and stable course of the disease.

Conclusion

The results of follow-up confirm the safety and efficacy of the long-term antifibrotic therapy with pirfenidone in IPF patients.

Key words

Idiopathic pulmonary fibrosis, antifibrotic therapy, pirfenidone.